| Reproductive factors and breast cancer risk: A meta-analysis of case–control studies in Indian women G Vishwakarma, H Ndetan, DN Das, G Gupta, M Suryavanshi, A Mehta, ... South Asian journal of cancer 8 (02), 080-084, 2019 | 51 | 2019 |
| Germline BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance associated with breast/ovarian cancer: a report from North India A Mehta, S Vasudevan, SK Sharma, D Kumar, M Panigrahi, ... Cancer management and research, 6505-6516, 2018 | 38 | 2018 |
| Thrombocytopenia in leptospirosis and role of platelet transfusion J Sharma, M Suryavanshi Asian Journal of Transfusion Science 1 (2), 52-55, 2007 | 26 | 2007 |
| Incidence of ROS1-Rearranged Non-Small-Cell Lung Carcinoma in India and Efficacy of Crizotinib in Lung Adenocarcinoma Patients A Mehta, M Saifi, U Batra, M Suryavanshi, K Gupta Lung Cancer: Targets and Therapy, 19-25, 2020 | 19 | 2020 |
| Detection of false positive mutations in BRCA gene by next generation sequencing M Suryavanshi, D Kumar, MK Panigrahi, M Chowdhary, A Mehta Familial cancer 16, 311-317, 2017 | 19 | 2017 |
| Biomarker testing for advanced lung cancer by next-generation sequencing; a valid method to achieve a comprehensive glimpse at mutational landscape A Mehta, S Vasudevan, SK Sharma, M Panigrahi, M Suryavanshi, M Saifi, ... Applied Cancer Research 40, 1-12, 2020 | 15 | 2020 |
| MET amplification and response to MET inhibitors in stage IV lung adenocarcinoma M Suryavanshi, A Shah, D Kumar, MK Panigrahi, A Metha, U Batra Oncology Research and Treatment 40 (4), 198-202, 2017 | 14 | 2017 |
| CSF cell-free DNA EGFR testing using DdPCR holds promise over conventional modalities for diagnosing leptomeningeal involvement in patients with non-small cell lung cancer M Suryavanshi, J Jaipuria, MK Panigrahi, N Goyal, R Singal, A Mehta, ... Lung Cancer 148, 33-39, 2020 | 13 | 2020 |
| Genetic counseling, testing, and management of HBOC in India: an expert consensus document from Indian Society of Medical and Pediatric Oncology H Malhotra, P Kowtal, N Mehra, R Pramank, R Sarin, T Rajkumar, S Gupta, ... JCO Global Oncology 6, 991-1008, 2020 | 13 | 2020 |
| Quantification of DNA extracted from formalin fixed paraffin-embeded tissue comparison of three techniques: Effect on PCR efficiency D Kumar, MK Panigrahi, M Suryavanshi, A Mehta, KK Saikia Journal of clinical and diagnostic research: JCDR 10 (9), BC01, 2016 | 13 | 2016 |
| Stem cell therapy: A paradigm shift in breast cancer treatment S Khan, M Suryavanshi, J Kaur, D Nayak, A Khurana, RK Manchanda, ... World journal of stem cells 13 (7), 841, 2021 | 12 | 2021 |
| S100P as a marker for urothelial histogenesis: A critical review and comparison with novel and traditional urothelial immunohistochemical markers M Suryavanshi, J Sanz-Ortega, D Sirohi, MK Divatia, C Ohe, C Zampini, ... Advances in anatomic pathology 24 (3), 151-160, 2017 | 12 | 2017 |
| Liquid biopsy: A potential and promising diagnostic tool for advanced stage non-small cell lung cancer patients DC Doval, R Deshpande, B Dhabhar, KG Babu, K Prabhash, R Chopra, ... Indian Journal of Cancer 54 (Suppl 1), S25-S30, 2017 | 10 | 2017 |
| Weaker ERG expression in patients with ERG-positive prostate cancer is associated with advanced disease and weaker androgen receptor expression: An Indian outlook M Suryavanshi, A Mehta, J Jaipuria, AK Sharma, S Rawal, N Seth Urologic Oncology: Seminars and Original Investigations 33 (7), 331. e9-331. e15, 2015 | 10 | 2015 |
| Audit of molecular mechanisms of primary and secondary resistance to various generations of tyrosine kinase inhibitors in known epidermal growth factor receptor-mutant non … M Suryavanshi, J Jaipuria, S Mattoo, S Dhandha, M Khatri Clinical Oncology 34 (11), e451-e462, 2022 | 9 | 2022 |
| Prognostic role of microRNA 182 and microRNA 18a in locally advanced triple negative breast cancer R Bajaj, R Tripathi, TS Sridhar, A Korlimarla, KD Choudhury, ... PloS one 15 (11), e0242190, 2020 | 9 | 2020 |
| EGFR mutation testing on plasma and urine samples: a pilot study evaluating the value of liquid biopsy in lung cancer diagnosis and management S Satapathy, V Singh, A Nambirajan, PS Malik, P Tanwar, A Mehta, ... Current Problems in Cancer 45 (6), 100722, 2021 | 8 | 2021 |
| The detection of primary and secondary EGFR mutations using droplet digital PCR in patients with nonsmall cell lung cancer M Suryavanshi, A Mehta, MK Panigrahi, J Jaipuria, M Saifi, K Jain, ... Lung India 35 (5), 384-389, 2018 | 8 | 2018 |
| ROS1 rearrangement and response to crizotinib in Stage IV non-small cell lung cancer M Suryavanshi, MK Panigrahi, D Kumar, H Verma, M Saifi, B Dabas, ... Lung India 34 (5), 411-414, 2017 | 8 | 2017 |
| Predictive biomarkers in nonsmall cell carcinoma and their clinico-pathological association A Mehta, NN Sriramanakoppa, P Agarwal, G Viswakarma, S Vasudevan, ... South Asian journal of cancer 8 (04), 250-254, 2019 | 7 | 2019 |
